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Objective
There is high case-fatality rate and loss of productive life-years related to aneurysmal subarachnoid hemorrhage (aSAH) but little data on long-term survival of SAH patients. We aim to evaluate long-term excess mortality and related risk factors after aSAH. 
Methods
Results
After 20 years, survivors of aSAH showed 18% excess mortality compared to general population. Risk factors included: old age; poor preoperative clinical condition; conservative aneurysm treatment; multiple aneurysms; and unfavourable clinical outcome at 3 months.
Conclusion
Even after initially favourable recovery, patients with aSAH experience excess mortality in the long run. Cardiovascular and cerebrovascular diseases are prominent in this population. Patients who survive the initial hours after the bleeding, three major neurological complications can threaten: rebleeding, delayed brain ischemia and hydrocephalus, all of which cause severe morbidity and mortality during the first months after SAH (5-7).
The case-fatality rate for aneurysmal SAH is still close to 50% even though it has improved slowly over time thanks to better diagnostic tools and improved medical and surgical treatment strategies (2) . Even nowadays, although only 5-10% of all strokes are caused by subarachnoid hemorrhage, the loss of productive life years is similar to that for cerebral infarction or intracerebral hemorrhage, since SAH strikes at fairly young age and is often fatal (8) . Half of the patients are younger than 55 years (8) . Despite the known high case-fatality rate of SAH up to 6 months, there is only very little data on what happens to SAH patients later on. Is their life expectancy similar to that of somebody who has never had SAH or are they more prone to develop other medical conditions leading to morbidity and mortality? The aim of this study is to find out if there is excess mortality among patients with aneurysmal SAH in the long run, compared to matched general population.
There are only few publications on long-term survival of SAH patients and their conclusions are slightly contradicting (1, (9) (10) (11) (12) . Most studies have shown at least some excess mortality among SAH patients when compared to matched general population (1, 9, 11, 12) , whereas other results suggest quite the opposite (10) . Knowledge on prospects of long-term survival and recovery after aneurysmal SAH is important for the patients, their families as well as for those deciding on the use of health economy resources. More information is needed concerning long-term mortality of SAH patients and the risk factors related to impaired survival. Some of the risk factors may be treatable and this way the prognosis may be improved. For example, are multiple aneurysms predisposing factor for long-term mortality? Some patients are more prone to develop multiple aneurysms but it is not known whether these patients should be followed-up or treated more actively than those with just a single aneurysm.
Patients and Methods
Patients and Helsinki Cerebral Aneurysm Research--Data base
This is a single institution, retrospective follow-up study. There were altogether 4228 SAH patients forming the final study sample. Characteristics of these 3080 subarachnoid hemorrhage patients are shown in Table 1 . The mean age at the incidence of SAH was 49
(range 1-88). For women the mean age was 51 and for men 46 years.
Follow--Up Data
Follow-up period started one year after the initial SAH and continued until death or the end of Neurosurgical Societies (WFNS) grading scales (13, 14) . For the purpose of data analysis, patients were assigned either to active or conservative treatment group based on the treatment they received. Treatment was considered conservative if the patient did not receive any kind of neurosurgical operative or endovascular intervention at any point during the whole follow-up period. Clinical condition at 3 months after the onset of SAH was evaluated using Glasgow outcome score (GOS) (15) . The total follow-up time was 36 960 patient-years with median follow-up of 12 years per patient (range 1-29 year(s)). 
Ethical Aspects
This study has been carried out following good ethical manner. It has been approved by the Ethics Committee of the Helsinki University Central Hospital, Dnro: 469/E0/04. 
Results
Mortality
Causes of Death and Recurrent SAH
During the follow-up, 713 patients (23%) died. Table 2 shows the causes of death in relation to follow-up periods. There were altogether 122 deaths caused by SAH over the whole time period. Majority of them (n=87, 71%) were related to the initial SAH. Rebleeding before treatment or rebleeding from previously treated aneurysm was cause of death in 18 patients and 17 died due to rupture of another aneurysm. The incidence for lethal recurrent SAH was 95 per 100 000 person-years, which is about three times the risk of getting SAH as a general Finnish adult (incidence 35/100 000) (17) .
Among the study group, the patients who survived a minimum of one year after SAH, the mean age at death was 65 (median 66; range 23-90). The most common causes of death were cardiovascular disease (26%) and cancer (22%). Patients younger than 65 years also had cardiovascular disease as the leading cause of death (24%). Deaths caused by cerebrovascular disease were also common in our study group (15% for ≥ 65 years , 8%
< 65 years). 
Excess in Long--Term Mortality
There was constant excess mortality throughout the whole study period in study population compared to matched general population. Cumulative RSR was 0.94 (95% CI 0.93 -0.95) at 10 years, 0.82 (95% CI 0.79-0.85) at 20 years and 0.75 (95% CI 0.70 -0.81) at 28 years indicating excess mortality of 6%, 18% and 25% respectively.
Cumulative relative survival ratios (RSRs) are presented in Figure 1 . Even the youngest age group, patients aged 44 or younger, had significant excess longterm mortality (25-year cumulative RSR 0.84, 95% CI 0.80 -0.88) compared to matched general population. Of these younger patients, who died during the follow-up, 95% died before the age of 65. The patients aged 44 or younger seemed to have excess mortality caused by sequelae of SAH (n=37), cardiovascular disease (n=39) and cerebrovascular disease (n=14) accounting 20%, 21% and 8% of all causes of death respectively.
Figure 2
Cumulative RSRs as a function of follow--up time for three age groups: ≤44 years (blue), 45-59 years (green), and ≥60 years (purple).
Multiple Aneurysms
Patients with a single aneurysm had better survival (n=2177, 25-year cumulative RSR Cumulative relative survival ratios (RSRs) are shown in figure 3 . 
Figure 6
Cumulative RSRs of SAH patients, divided into groups according to the location of ruptured aneurysm and presented as a function of time.
Outcome at 3 months
As expected, patients who had serious disabilities at three months after SAH also had greater long-term excess mortality when compared to patients with good recovery according to Glasgow outcome score (Figure 7 ). Considering patients with GOS 2, 67% of them died because of SAH.
Remarkably, patients with good recovery after the SAH also had notable excess in longterm mortality but they did not start to show it until after 8 years of follow-up (25-year cumulative RSR for GOS 5 0.85, 95% CI 0.80-0.90). Patients with good recovery at 3 months had cardiovascular disease (31%) and cancer (27%) as the leading causes of death. They had the lowest portion of deaths caused by SAH (9% GOS 5 vs. 12% GOS 4 and 20% GOS 3).
Figure 7
Cumulative RSRs as a function of time according to patients´ clinical outcome at 3 months after SAH: GOS 5 Good Recovery (yellow), GOS 4 Moderate Disability (purple), GOS 3 Severe Disability (green) and GOS 2 Persistent vegetative state (blue).
Discussion
In this follow-up study of 3080 aneurysmal SAH patients, there was constant excess mortality throughout the whole study period. The cumulative relative survival ratios showed 18% excess mortality at 20 years compared to the matched Finnish general population.
Even young patients and patients with good recovery showed excess mortality in the long run. The excess mortality became more obvious after ten years of follow-up and was highlighted during the following decades. The advantages of this study were: (a) exceptionally large number of study patients; (b) extensive follow-up of nearly 37 000 patient-years; (c) low number of excluded patients in comparison to the whole study group and (d) detailed population registers and mortality statistics in Finland, which include all Finnish residents. The fact that this is a retrospective follow-up study caused some selection bias that needs to be considered when looking at the results.
Long--term Mortality after SAH
So far, there is only limited knowledge on the long-term follow-up of aneurysmal SAH patients. Most studies report outcome at relatively early phase of recovery, most often three to 12 months after the SAH (2, 8, 17, 18) There are very few studies which address patients' outcome more than five years after the initial SAH (1,9-12). The general belief has been, that after successful recovery, SAH should have no further effect on patients'
survival. However, what some studies have shown is, that despite surviving the initial aSAH, many of the patients die earlier than their peers (1, 9, 11, 12) .
In earlier Finnish study of 1537 SAH patients by Ronkainen et al. it was suggested that aneurysmal SAH might be a manifestation of general vascular disease (9) . The study by
Wermer et al. from the Netherlands suggested that treatment of cardiovascular risk factors should be considered due to elevated incidence of vascular events (11) . The most common causes of death in our study group were cardiovascular disease (26%) and cancer (22%). Among patients with good recovery at 3 months, these were highlighted as the leading causes of death (31% and 27% respectively). Patients younger than 65 years had cardiovascular disease as the leading cause of death (24% Deaths caused by cerebrovascular disease were also overrepresented among our study patients (15% for ≥ 65 years, 8% < 65 years) compared to general Finnish population (11% for ≥ 65 years, 6% < 65 years) (19) . A significant cause of mortality were sequelae of the initial SAH. They counted about one fifth of all deaths in the first five-year period but were less prominent later on. It is possible that long-term rehabilitation and follow-up of SAH patients is not optimal nowadays. The effects and disabilities caused by SAH may not be paid enough attention to in the years following SAH, which may increase morbidity and mortality.
The risk of lethal recurrent SAH was not high but remained elevated after primary SAH.
Long-term risk of rebleeding from previously treated aneurysm seemed to be greatest during the first five-year period of follow-up and decreased after that. The risk of new, lethal SAH from another aneurysm did not lower in a long run. It was higher among patients with multiple aneurysms than among patients with a single aneurysm. The total risk of lethal, recurrent SAH was about three times as high as the risk of SAH striking for the first time.
Long--term Excess Mortality
There are only five publications on long-term mortality of aneurysmal SAH patients (1, (9) (10) (11) (12) . Three of these studies come from Finland, one from Iceland and one from the Netherlands, indicating how difficult it is to carry out a reliable long-term follow-up study.
The results are partly contradicting, especially when it comes to survival of young patients and the patients with good recovery after SAH.
In our study, the total cumulative relative survival ratios showed 18% excess mortality at These findings are similar, both presenting significant long-term excess mortality after SAH. Eventhough both of these studies are from Finland, the method of calculating RSRs, using matched general population, should fade the effect of the population it is based upon and describe only the effect of SAH.
Risk Factors for Excess Mortality
Risk factors for long-term excess mortality turned out to be: age (especially above 60 years); poor preoperative clinical condition; conservative treatment; multiple aneurysms;
and unfavourable clinical outcome at 3 months after the SAH.
Age
The patients aged 60 and older were in the greatest risk of dying earlier than their fellow citizens according to our series. This is in line with the recent study of Huttunen et al. in which age above 64 years was an independent risk factor for long-term excess mortality (12) . In the Dutch study of 752 SAH patients by Wermer et al., young patients had the highest excess mortality and earlier study by Ronkainen et al. suggested the same (9,11).
In our study, age group of 60-88 showed the highest excess mortality. But, there was significant excess mortality of 16% at 25-years of follow-up even in our youngest age group (1-44 years). These patients died at ages much younger than their peers, with sequelae of the initial SAH, cardiovascular and cerebrovascular disease representing half of all the causes of death.
Preoperative Clinical Condition
It was expected that poor preoperative clinical condition leads to impaired survival.
Surprisingly, even patients with good preoperative clinical condition showed excess mortality during follow-up. This was seen in using both HH and WFNS grading scales.
There was excess mortality of 9% at 20 years for patients with HH 1 and 14% at 20 years for patients with HH 2. Similar results were seen in the study of Huttunen et al. who
reported 11% excess mortality at 15 years for patients with HH 1-2 on admission (12).
Conservative Treatment
The conservatively treated patients had markedly higher excess mortality than patients who got active treatment. The selection bias, related to this study, affects especially allocation into these two treatment groups. The conservative treated patients were initially in worse clinical condition and were expected to have worse prognosis in comparison to actively treated patients. In addition, 89% of the conservatively treated patients died during the first year of follow-up, as compared to the 14% of actively treated.
Multiple Aneurysms
We got new information concerning the prognosis of the patients with multiple aneurysms.
They had not only higher excess mortality but also increased risk of dying due to rupture of another aneurysm than patients with just single aneurysm. It is not known if treating all the aneurysms early enough will decrease their mortality but this is something we would like to study in the future. It is possible that patients with multiple aneurysms have more severe general vascular disease, and multiplicity of aneurysms is just a representation of the severity of the disease. When looking at causes of death this can not be verified; cardiovascular disease (27% for single aneurysm group, 24% for multiple aneurysm patients), and cerebrovascular disease (13% and 12% respectively).
Clinical Outcome at 3 Months
It has been a generally accepted belief, that after good recovery, SAH patients should have the same life expectancy as other people. An Icelandic study of only 44 SAH patients showed no excess mortality among patients with good recovery at 6 months (1). Also in a
Finnish series of 280 ruptured distal anterior cerebral artery aneurysm patients, there was no long-term excess mortality for patients with good recovery at 12 months (10). The first study was limited by a small number, whereas in the latter one certain distinct features of the distal anterior cerebral artery aneurysms such as their frontal and cortical location, may explain the relatively better outcome when compared to all aneurysm locations. Our results seem to be in line with the other two larger studies which included all aneurysm sites. They reported excess mortality (9% or twice that of the general population) even in patients with initial good recovery (9, 12) . In our study, patients with good recovery at 3 months showed 15% cumulative excess mortality in 25-year follow-up. The excess mortality was not clearly seen during the first ten years but became evident after that. So, contrary to the general belief, even patients with good initial recovery after aSAH are burdened by their SAH experience and die earlier than matched population.
Gender and Location of Aneurysm -No Related Risk
Gender or location of the ruptured aneurysm had no effect on long-term survival according to our data. These results are not supported by the study of Huttunen et al., which suggested that male sex and basilar tip aneurysms were related to long-term excess mortality (12) . In our study the mortality related to basilar tip aneurysms was elevated during the first year after the SAH but later on it did not differ from the mortality of the patients with aneurysms at other locations.
Conclusions
Despite initial good recovery aneurysmal SAH patients are burdened by the SAH in the long run. They show significant long-term excess mortality when compared with matched general population. Risk factors for excess mortality are old age, poor preoperative clinical condition, conservative aneurysm treatment, multiple aneurysms and unfavourable clinical outcome at 3 months after SAH. Cardiovascular disease at younger age and cerebrovascular events are overrepresented as causes of death, which indicates the importance of treatment of cardio-and cerebrovascular risk factors after SAH.
